Nagai N, Oshita T, Mukai K, Shiroyama Y, Shigemasa K, Ohama K
human evidence is still emerging.) Musculoskeletal injury or post-surgical recovery Chronic tendonitis, ligament sprains, or joint pain Athletes or active individuals with overuse injuries Patients with GI inflammation or ulcerative symptoms Individuals seeking regenerative or anti-inflammatory support Generally well-tolerated in available data, but may include: Mild redness or irritation at injection site Transient headache, nausea, or dizziness (rare) Potential for allergic reaction (rare) Not FDA-approved
Factors like skin type, pigmentation severity, and product concentration all influence the timeline
Reported, but not confirmed in a controlled study Important limits Frequency, dose link, and cause are unknown